Therapeutic regimen interpretation of American AAO-HNSF guidelines for sudden hearing loss (2019 update)_Chinese Journal of Evidence-Based Medicine

Authors：

LI Hao ^1,2 , ZHU Zunyi ^1,2 , XIE Han ^2,3 ,  GE Weihong ^2,3

1. Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing 210029, P. R. China;
2. Department of Pharmacy, Affiliated Drum Tower Hospital of Nanjing University, Nanjing 210008, P. R. China;
3. Nanjing Medical Center of Clinical Pharmacy, Affiliated Drum Tower Hospital of Nanjing University, Nanjing 210008, P. R. China;

Corresponding author：

GE Weihong, Email: glg6221230@163.com

Keywords：

Sudden hearing loss; Drug treatment; Non-drug treatment; Recommendations; Evidence

DOI：

10.7507/1672-2531.202211112

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

The American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) published the first clinical practice guideline for sudden sensorineural hearing loss in 2012 and updated it in 2019. The guideline, which includes 13 expert consensus recommendations and treatment protocols, advocates medication (glucocorticoids are the sole optional medicine) and hyperbaric oxygen therapy. In order to provide references for the formulation of the guidelines for sudden sensorineural hearing loss that are more suitable for our national conditions, this article interprets the treatment regimens of the guideline.

Citation： LI Hao, ZHU Zunyi, XIE Han, GE Weihong. Therapeutic regimen interpretation of American AAO-HNSF guidelines for sudden hearing loss (2019 update). Chinese Journal of Evidence-Based Medicine, 2023, 23(7): 755-759. doi: 10.7507/1672-2531.202211112 Copy

1.	Chuang KF, Liu FC, Chen HC. Bilateral sudden sensorineural hearing loss in patient with Behçet disease. Ear Nose Throat J, 2021, 18: 20-43.
2.	Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg, 2012, 161: 1-45.
3.	Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical practice guideline: sudden hearing loss (Update). Otolaryngol Head Neck Surg, 2019, 161: 1-45.
4.	Becker DE. Basic and clinical pharmacology of glucocorticosteroids. Anesth Prog, 2013, 60(1): 25-31.
5.	Chen CY, Halpin C, Rauch SD. Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol, 2003, 24(5): 728-733.
6.	Ghosh A, Jackson R. Best evidence topic report. Steroids in sudden sensorineural hearing loss. Emerg Med J, 2005, 22(10): 732-733.
7.	Jeyakumar A, Francis D, Doerr T. Treatment of idiopathic sudden sensorineural hearing loss. Acta Otolaryngol, 2006, 126(7): 708-713.
8.	Moskowitz D, Lee KJ, Smith HW. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope, 1984, 94: 664-666.
9.	Slattery WH, Fisher LM, Iqbal Z, et al. Oral steroid regimens for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg, 2005, 132(1): 5-10.
10.	Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol, 2005, 26(5): 878-881.
11.	Cvorović L, Deric D, Probst R, et al. Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss. Otol Neurotol, 2008, 29(4): 464-469.
12.	El Sabbagh NG, Sewitch MJ, Bezdjian A, et al. Intratympanic dexamethasone in sudden sensorineural hearing loss: a systematic review and meta-analysis. Laryngoscope, 2017, 127(8): 1897-1908.
13.	Wei BP, Stathopoulos D, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev, 2013, (7): CD003998.
14.	Cinamon U, Bendet E, Kronenberg J. Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol, 2001, 258(9): 477-480.
15.	Stachler RJ, Chandrasekhar SS, Archer SM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg, 2012, 146(Suppl 3): S1-S35.
16.	Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol, 2001, 22(1): 18-23.
17.	Filipo R, Attanasio G, Russo FY, et al. Intratympanic steroid therapy in moderate sudden hearing loss: a randomized, triple-blind, placebo-controlled trial. Laryngoscope, 2013, 123(3): 774-778.
18.	Lee JB, Choi SJ, Park K, et al. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol, 2011, 268(6): 833-839.
19.	Li P, Zeng XL, Ye J, et al. Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study. Audiol Neurootol, 2011, 16(3): 198-202.
20.	Wu HP, Chou YF, Yu SH, et al. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study. Otol Neurotol, 2011, 32(5): 774-779.
21.	Nadol J, Wilson W. Treatment of sudden hearing loss is illogical. Controver in Otol, 1980: 22-32.
22.	Perlman HB, Kimura R, Fernandez C. Experiments on temporary obstruction of the internal auditory artery. Laryngoscope, 1959, 69(6): 591-613.
23.	Schuknecht HF, Kimura RS, Naufal PM. The pathology of sudden deafness. Acta Otolaryngol, 1973, 76(2): 75-97.
24.	Li Y. Interventions in the management of blood viscosity for idiopathic sudden sensorineural hearing loss: a meta-analysis. J Health Res and Rev, 2017, 4(2): 50-61.
25.	Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM, 2004, 97(7): 385-395.
26.	Mathur M. Sudden hearing loss. Medic, 2019: 260-300.
27.	Cvorovic L, Jovanovic MB, Milutinovic Z, et al. Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss. Otol Neurotol, 2013, 34(6): 1021-1026.
28.	Gülüstan F, Yazıcı ZM, Alakhras WME, et al. Intratympanic steroid injection and hyperbaric oxygen therapy for the treatment of refractory sudden hearing loss. Braz J Otorhinolaryngol, 2016, 84(1): 28-33.
29.	Gillick MR. Re-engineering shared decision-making. J Med Ethics, 2015, 41(9): 785-788.
30.	Satin DJ, Swenson SA, Stovitz SD. Effectively engaging patients in everyday health-care decisions. J Fam Pract, 2017, 66(10): E1-E6.
31.	Légaré F, Turcotte S, Stacey D, et al. Patients' perceptions of sharing in decisions: a systematic review of interventions to enhance shared decision making in routine clinical practice. Patient, 2012, 5(1): 1-19.
32.	周奇, 邢丹, 李沁原, 等. 指南解读类文献报告规范的制订指南(RIGHT for INT). 中国循证医学杂志, 2022, 22(5): 497-507.
33.	中华耳鼻咽喉头颈外科杂志编辑委员会, 中华医学会耳鼻咽喉头颈外科学分会. 突发性聋诊断和治疗指南(2015). 中华耳鼻咽喉头颈外科杂志, 2015, 50(6): 443-447.

1. Chuang KF, Liu FC, Chen HC. Bilateral sudden sensorineural hearing loss in patient with Behçet disease. Ear Nose Throat J, 2021, 18: 20-43.
2. Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg, 2012, 161: 1-45.
3. Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical practice guideline: sudden hearing loss (Update). Otolaryngol Head Neck Surg, 2019, 161: 1-45.
4. Becker DE. Basic and clinical pharmacology of glucocorticosteroids. Anesth Prog, 2013, 60(1): 25-31.
5. Chen CY, Halpin C, Rauch SD. Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol, 2003, 24(5): 728-733.
6. Ghosh A, Jackson R. Best evidence topic report. Steroids in sudden sensorineural hearing loss. Emerg Med J, 2005, 22(10): 732-733.
7. Jeyakumar A, Francis D, Doerr T. Treatment of idiopathic sudden sensorineural hearing loss. Acta Otolaryngol, 2006, 126(7): 708-713.
8. Moskowitz D, Lee KJ, Smith HW. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope, 1984, 94: 664-666.
9. Slattery WH, Fisher LM, Iqbal Z, et al. Oral steroid regimens for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg, 2005, 132(1): 5-10.
10. Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol, 2005, 26(5): 878-881.
11. Cvorović L, Deric D, Probst R, et al. Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss. Otol Neurotol, 2008, 29(4): 464-469.
12. El Sabbagh NG, Sewitch MJ, Bezdjian A, et al. Intratympanic dexamethasone in sudden sensorineural hearing loss: a systematic review and meta-analysis. Laryngoscope, 2017, 127(8): 1897-1908.
13. Wei BP, Stathopoulos D, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev, 2013, (7): CD003998.
14. Cinamon U, Bendet E, Kronenberg J. Steroids, carbogen or placebo for sudden hearing loss: a prospective double-blind study. Eur Arch Otorhinolaryngol, 2001, 258(9): 477-480.
15. Stachler RJ, Chandrasekhar SS, Archer SM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg, 2012, 146(Suppl 3): S1-S35.
16. Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol, 2001, 22(1): 18-23.
17. Filipo R, Attanasio G, Russo FY, et al. Intratympanic steroid therapy in moderate sudden hearing loss: a randomized, triple-blind, placebo-controlled trial. Laryngoscope, 2013, 123(3): 774-778.
18. Lee JB, Choi SJ, Park K, et al. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol, 2011, 268(6): 833-839.
19. Li P, Zeng XL, Ye J, et al. Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study. Audiol Neurootol, 2011, 16(3): 198-202.
20. Wu HP, Chou YF, Yu SH, et al. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study. Otol Neurotol, 2011, 32(5): 774-779.
21. Nadol J, Wilson W. Treatment of sudden hearing loss is illogical. Controver in Otol, 1980: 22-32.
22. Perlman HB, Kimura R, Fernandez C. Experiments on temporary obstruction of the internal auditory artery. Laryngoscope, 1959, 69(6): 591-613.
23. Schuknecht HF, Kimura RS, Naufal PM. The pathology of sudden deafness. Acta Otolaryngol, 1973, 76(2): 75-97.
24. Li Y. Interventions in the management of blood viscosity for idiopathic sudden sensorineural hearing loss: a meta-analysis. J Health Res and Rev, 2017, 4(2): 50-61.
25. Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM, 2004, 97(7): 385-395.
26. Mathur M. Sudden hearing loss. Medic, 2019: 260-300.
27. Cvorovic L, Jovanovic MB, Milutinovic Z, et al. Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss. Otol Neurotol, 2013, 34(6): 1021-1026.
28. Gülüstan F, Yazıcı ZM, Alakhras WME, et al. Intratympanic steroid injection and hyperbaric oxygen therapy for the treatment of refractory sudden hearing loss. Braz J Otorhinolaryngol, 2016, 84(1): 28-33.
29. Gillick MR. Re-engineering shared decision-making. J Med Ethics, 2015, 41(9): 785-788.
30. Satin DJ, Swenson SA, Stovitz SD. Effectively engaging patients in everyday health-care decisions. J Fam Pract, 2017, 66(10): E1-E6.
31. Légaré F, Turcotte S, Stacey D, et al. Patients' perceptions of sharing in decisions: a systematic review of interventions to enhance shared decision making in routine clinical practice. Patient, 2012, 5(1): 1-19.
32. 周奇, 邢丹, 李沁原, 等. 指南解读类文献报告规范的制订指南(RIGHT for INT). 中国循证医学杂志, 2022, 22(5): 497-507.
33. 中华耳鼻咽喉头颈外科杂志编辑委员会, 中华医学会耳鼻咽喉头颈外科学分会. 突发性聋诊断和治疗指南(2015). 中华耳鼻咽喉头颈外科杂志, 2015, 50(6): 443-447.

Chinese Journal of Evidence-Based Medicine

Therapeutic regimen interpretation of American AAO-HNSF guidelines for sudden hearing loss (2019 update)

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content